{"protocolSection":{"identificationModule":{"nctId":"NCT05305625","orgStudyIdInfo":{"id":"XYFY2022-KL026"},"organization":{"fullName":"The Affiliated Hospital of Xuzhou Medical University","class":"OTHER"},"briefTitle":"Effect of Remote Ischemic Postcondioning on Glymphatic System in Acute Stroke","officialTitle":"Effect of Remote Ischemic Postcondioning on Glymphatic System in Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2022-01","overallStatus":"UNKNOWN","lastKnownStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-05-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2023-05-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-05-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-01-25","studyFirstSubmitQcDate":"2022-03-30","studyFirstPostDateStruct":{"date":"2022-03-31","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-03-30","lastUpdatePostDateStruct":{"date":"2022-03-31","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"The Affiliated Hospital of Xuzhou Medical University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Investigators aimed to investigate the changes of glymphatic function after remote ischemic postcondioning treatment in acute ischemic stroke ."},"conditionsModule":{"conditions":["Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["PARTICIPANT"]}},"enrollmentInfo":{"count":60,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"standard therapy","type":"EXPERIMENTAL","description":"Patients will be treated with Guideline standard","interventionNames":["Drug: standard therapy"]},{"label":"remote ischemic postcondioning and standard therapy","type":"EXPERIMENTAL","description":"Patients will be treated with remote ischemic postcondioning and Guideline standard , remote ischemic postcondioning twice a day for a total of 3 days.","interventionNames":["Procedure: remote ischemic postcondioning","Drug: standard therapy"]}],"interventions":[{"type":"PROCEDURE","name":"remote ischemic postcondioning","description":"remote ischemic postcondioning twice daily, for three consecutive days，the upper arm of the lighter paralyzed side was pressurized to 200mmHg, pressurized 5min and relaxed for 5 minutes for 4 cycles as a complete remote ischemic postcondioning","armGroupLabels":["remote ischemic postcondioning and standard therapy"]},{"type":"DRUG","name":"standard therapy","description":"received standardized treatment","armGroupLabels":["remote ischemic postcondioning and standard therapy","standard therapy"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Changes of glial lymphatic system","description":"The size of the vascular spaces was assessed by brain magnetic resonance of ischemic postcondioning group and standard therapy group","timeFrame":"from baseline to 3 day"}],"secondaryOutcomes":[{"measure":"Differential expression pattern of differential proteins","description":"Differential expression pattern of differential proteins in blood of patients with remote ischemic postcondioning group and standard therapy group","timeFrame":"from baseline to 3 day"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The patient was 18-80 years old;\n* The NIHSS score was ≤ 25 and NIHSS \\> 5，Glasgow coma score ≥ 8;\n* The patients were diagnosed as anterior circulation cerebral infarction and could start remote ischemic postcondioning within 24 hours after onset\n* Normal to random time within 24 hours\n* Written informed consent signed by patients or their families\n\nExclusion criteria:\n\n* patients receiving thrombolysis or endovascular therapy;\n* modified Rankin scale (mRS) score ≥ 2 before this attack;\n* other intracranial lesions, such as cerebral hemorrhage, cerebral venous disease, severe subclavian artery stenosis and other diseases involving the brain;\n* Arterial blood pressure ≤ 90/60mmHg or ≥ 180/100mmHg after treatment.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Yu Lu, MD","role":"CONTACT","phone":"0086-18151865060","email":"Yulumed@163.com"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}